Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, … , M Ferrarini, N Chiorazzi
F Fais, … , M Ferrarini, N Chiorazzi
Published October 15, 1998
Citation Information: J Clin Invest. 1998;102(8):1515-1525. https://doi.org/10.1172/JCI3009.
View: Text | PDF
Research Article Article has an altmetric score of 9

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  • Text
  • PDF
Abstract

To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.

Authors

F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1981 Total
Citations: 2 7 9 10 28 16 11 17 25 18 27 25 48 29 37 31 33 30 36 37 33 35 32 29 30 26 12 1 674
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2015 (27)

Title and authors Publication Year
Total proteome analysis identifies migration defects as a major pathogenetic factor in IGHV-unmutated chronic lymphocytic leukemia
GL Eagle, J Zhuang, RE Jenkins, KJ Till, PV Jithesh, K Lin, GG Johnson, M Oates, K Park, NR Kitteringham, AR Pettitt
Molecular & cellular proteomics : MCP 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
JS Blachly, AS Ruppert, W Zhao, S Long, J Flynn, I Flinn, J Jones, K Maddocks, L Andritsos, EM Ghia, LZ Rassenti, TJ Kipps, A la Chapelle, JC Byrd
Proceedings of the National Academy of Sciences 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
M Gounari, S Ntoufa, B Apollonio, N Papakonstantinou, M Ponzoni, CC Chu, D Rossi, G Gaidano, N Chiorazzi, K Stamatopoulos, P Ghia
Blood 2015
Restricted, canonical, stereotyped and convergent immunoglobulin responses
CJ Dunand, PC Wilson
Philosophical Transactions of the Royal Society B: Biological Sciences 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
RM Young, T Wu, R Schmitz, M Dawood, W Xiao, JD Phelan, W Xu, L Menard, E Meffre, WC Chan, ES Jaffe, RD Gascoyne, E Campo, A Rosenwald, G Ott, J Delabie, LM Rimsza, LM Staudt
Proceedings of the National Academy of Sciences 2015
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool
G Paciello, A Acquaviva, C Pighi, A Ferrarini, E Macii, A Zamo’, E Ficarra, Q Shi
PloS one 2015
The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia
LA Sutton, R Rosenquist
Seminars in Cancer Biology 2015
Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability
X Cui, L Zhang, AR Magli, R Catera, XJ Yan, DO Griffin, TL Rothstein, J Barrientos, JE Kolitz, SL Allen, KR Rai, N Chiorazzi, CC Chu
Leukemia 2015
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
S Martinelli, A Cuneo, GM Rigolin
Mediterranean journal of hematology and infectious diseases 2015
Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC  subversion induces up-regulation of PKC II expression in B lymphocytes
R Nakagawa, M Vukovic, A Tarafdar, E Cosimo, K Dunn, AM McCaig, A Holroyd, F McClanahan, AG Ramsay, JG Gribben, AM Michie
Haematologica 2015
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells
CC Yin, G Tang, G Lu, X Feng, MJ Keating, LJ Medeiros, LV Abruzzo
Modern Pathology 2015
Current Topics in Microbiology and Immunology
K Okkenhaug, JA Burger
Current topics in microbiology and immunology 2015
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
RD Innis-Shelton, RS Davis, L Lamb, S Mineishi
Leukemia & Lymphoma 2015
Hypermorphic mutation of phospholipase C,  2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
TM Liu, JA Woyach, Y Zhong, A Lozanski, G Lozanski, S Dong, E Strattan, A Lehman, X Zhang, JA Jones, J Flynn, LA Andritsos, K Maddocks, SM Jaglowski, KA Blum, JC Byrd, JA Dubovsky, AJ Johnson
Blood 2015
Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia
S Yepes, MM Torres, L López-Kleine
BMC Genomics 2015
Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis
S Molica, D Giannarelli, L Levato, M Gentile, R Mirabelli, F Morabito
Clinical Lymphoma Myeloma and Leukemia 2015
High-Throughput Sequencing Using the Ion Torrent Personal Genome Machine for Clinical Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia
R McClure, M Mai, S McClure
The Journal of Molecular Diagnostics 2015
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA
F Maura, G Cutrona, L Mosca, S Matis, M Lionetti, S Fabris, L Agnelli, M Colombo, C Massucco, M Ferracin, B Zagatti, D Reverberi, M Gentile, AG Recchia, S Bossio, D Rossi, G Gaidano, S Molica, A Cortelezzi, FD Raimondo, M Negrini, P Tassone, F Morabito, M Ferrarini, A Neri
Leukemia & Lymphoma 2015
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
S Molica, D Giannarelli, R Mirabelli, L Levato, A Russo, M Linardi, M Gentile, F Morabito
European Journal of Haematology 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?
B Tandon, SH Swerdlow, RP Hasserjian, U Surti, SE Gibson
Leukemia & Lymphoma 2015
A new piece to the stereotypy ‘puzzle’ in chronic lymphocytic leukemia
R Rosenquist
Leukemia & Lymphoma 2015
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
E Cornet, A Debliquis, V Rimelen, N Civic, M Docquier, X Troussard, B Drénou, T Matthes, M Baudis
PloS one 2015
Immunoglobulin gene expression in umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells
J Liu, M Xia, P Wang, C Wang, Z Geng, CC Yin, C Zhang, X Qiu
Gene 2015
Application of biomarkers in oncology clinical trials
N Dakappagari, H Gong, R Pollner, A Siva, S Tangri, J Lameh
Clinical Investigation 2015
SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients
T Mitsui, H Koiso, H Nakahashi, A Saitoh, H Shimizu, T Ishizaki, Y Ogawa, M Takizawa, A Yokohama, T Saitoh, T Jinbo, H Ogura, H Handa, M Sawamura, T Sakura, M Karasawa, H Murakami, Y Nojima, N Tsukamoto
International Journal of Hematology 2015
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
A Wiestner
Haematologica 2015
IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.
Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC
Oncotarget 2015

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 19 patents
290 readers on Mendeley
See more details